Technical Analysis for LMNX - Luminex Corporation

Grade Last Price % Change Price Change
grade D 20.155 1.72% 0.34
LMNX closed down 0.5 percent on Thursday, November 14, 2019, on 57 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical LMNX trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 1.72%
Narrow Range Bar Range Contraction 1.72%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.21%
20 DMA Support Bullish 1.21%
MACD Bullish Signal Line Cross Bullish 1.21%
Calm After Storm Range Contraction 1.21%
Narrow Range Bar Range Contraction 1.21%
NR7 Range Contraction 1.21%
Multiple of Ten Bearish Other 1.21%
Inside Day Range Contraction 1.21%

Older signals for LMNX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres; and MultiCode technology used for real-time polymerase chain reaction (PCR) and multiplexed PCR assays, as well as automation and robotics in the field of dry sample handling. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment's products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company's proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company has a collaboration and license agreement with Merck & Co., Inc. to develop a companion diagnostic device. Luminex Corporation was founded in 1995 and is headquartered in Austin, Texas.
Life Sciences Pharmaceutical Chemical Natural Sciences Infectious Disease Laboratory Techniques Digital Signal Processing DSP Luminex Corporation Real Time Polymerase Chain Reaction
Is LMNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 30.16
52 Week Low 17.345
Average Volume 184,222
200-Day Moving Average 21.8334
50-Day Moving Average 20.5104
20-Day Moving Average 19.8438
10-Day Moving Average 19.213
Average True Range 0.8423
ADX 20.18
+DI 21.3482
-DI 23.0274
Chandelier Exit (Long, 3 ATRs ) 19.4131
Chandelier Exit (Short, 3 ATRs ) 19.8719
Upper Bollinger Band 21.9747
Lower Bollinger Band 17.7129
Percent B (%b) 0.49
BandWidth 21.476733
MACD Line -0.2857
MACD Signal Line -0.3263
MACD Histogram 0.0406
Fundamentals Value
Market Cap 873.26 Million
Num Shares 44.1 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 61.92
Price-to-Sales 2.97
Price-to-Book 2.08
PEG Ratio 0.67
Dividend 0.24
Dividend Yield 1.21%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.31
Resistance 3 (R3) 20.29 20.12 20.23
Resistance 2 (R2) 20.12 19.99 20.12 20.20
Resistance 1 (R1) 19.97 19.91 20.04 19.98 20.17
Pivot Point 19.79 19.79 19.83 19.80 19.79
Support 1 (S1) 19.64 19.66 19.71 19.65 19.46
Support 2 (S2) 19.46 19.59 19.47 19.43
Support 3 (S3) 19.31 19.46 19.41
Support 4 (S4) 19.32